Sulcal Depth and Genetic Susceptibility Influence Initial Treatment Response in Adults With Attention-Deficit/Hyperactivity Disorder
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · 2025
DOI: 10.1016/j.bpsc.2025.09.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2025. Verfasst von Jonathan Laatsch und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany. Electronic address: jonathan.laatsch@ukbonn.de. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Genetic Predisposition to Disease, Cerebral Cortex. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMBF Bonn.
Abstract (Originalsprache)
BACKGROUND: As neurobiological markers gain prominence in guiding personalized treatments, sulcal depth (SD) remains an underexplored yet pivotal factor in neural processing and therapeutic efficacy. While genetic influences shape cortical architecture, their role in modulating the relationship between SD and treatment outcomes remains unclear. In this study, we investigated whether pretreatment SD predicts symptom alleviation in adults with attention-deficit/hyperactivity disorder (ADHD) and explored moderating effects of genetic susceptibility for ADHD and cross-disorder influences. METHODS: Using structural neuroimaging data from COMPAS (Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study), we examined associations between SD and treatment response following a 12-week intervention involving either group psychotherapy or clinical management with methylphenidate or placebo. Pretreatment SD was derived from 119 T1-weighted anatomical scans and analyzed using linear regression models to assess its predictive value for posttreatment symptom severity. Subsequently, we explored the moderating role of polygenic scores for ADHD and cross-disorder susceptibility. Structural analyses were performed using the threshold-free cluster enhancement approach in CAT, with moderation analyses conducted in SPSS. RESULTS: Results revealed that SD in parietal, temporal, and occipital regions significantly predicted symptom alleviation, linking deeper sulci with greater treatment efficacy. Moreover, genetic predisposition to ADHD and cross-disorder traits influenced these relationships, highlighting an interaction between cortical structure and genetic susceptibility in determining treatment outcomes. CONCLUSIONS: These findings highlight SD as a promising neurobiological marker of ADHD treatment response and emphasize the importance of integrating neurobiological and genetic factors into predictive models of therapeutic efficacy in psychiatry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany. Electronic address: jonathan.laatsch@ukbonn.de.
- Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany; Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
- Department of Psychiatry and Psychotherapy, University of Marburg, Marburg, Germany.
- Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Centre for Human Genetics, University of Marburg, Marburg, Germany.
- Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany; Institute of Neuroscience and Medicine, Research Center Jülich, Jülich, Germany.
- Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Förderung
- BMBF Bonn
Zitieren
APA
Laatsch, J., David, F. S., Stein, F., Maj, C., Forstner, A. J., Maier, S., Matthies, S., Sobanski, E., Alm, B., Tebartz van Elst, L., Krug, A., & Philipsen, A. (2025). Sulcal Depth and Genetic Susceptibility Influence Initial Treatment Response in Adults With Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. https://doi.org/10.1016/j.bpsc.2025.09.012
Vancouver
Laatsch J, David FS, Stein F, Maj C, Forstner AJ, Maier S, et al. Sulcal Depth and Genetic Susceptibility Influence Initial Treatment Response in Adults With Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2025. doi:10.1016/j.bpsc.2025.09.012
BibTeX
@article{Laatsch2025,
author = {Laatsch, Jonathan and David, Friederike S and Stein, Frederike and Maj, Carlo and Forstner, Andreas J and Maier, Simon and Matthies, Swantje and Sobanski, Esther and Alm, Barbara and Tebartz van Elst, Ludger and Krug, Axel and Philipsen, Alexandra},
title = {Sulcal Depth and Genetic Susceptibility Influence Initial Treatment Response in Adults With Attention-Deficit/Hyperactivity Disorder},
journal = {Biological Psychiatry: Cognitive Neuroscience and Neuroimaging},
year = {2025},
doi = {10.1016/j.bpsc.2025.09.012}
}
EUVIMED